Intensity Modulated Radiotherapy Market Share, Size, Trends, Industry Analysis Report, By Radiation Type (Proton radiation, Electron radiation, Photon radiation, Carbon-ion radiation); By Application; By End User; By Region; Segment Forecast, 2024 - 2032
- Published Date:Feb-2024
- Pages: 119
- Format: PDF
- Report ID: PM4628
- Base Year: 2023
- Historical Data: 2019-2022
Report Outlook
Intensity Modulated Radiotherapy Market size was valued at USD 1.70 billion in 2023. The market is anticipated to grow from USD 1.76 billion in 2024 to USD 2.59 billion by 2032, exhibiting a CAGR of 5.0% during the forecast period.
Market Overview
Intensity-modulated radiotherapy (IMRT) is one of the most prominent developments in oncology. This therapy is gaining utility with the rising number of benign tumors and cancers in the world. The enormous strength of providing the required dosage of radiation to the cancer cells in the human body is creating new growth opportunities for intensity-modulated radiotherapy in the global market. The ongoing research studies delving into the potential benefits associated with the IMRT are likely to promote its demand in the oncology segment.
- For instance, a 2023 study presented at the 2023 World Conference on Lung Cancer revealed that the people treated with the IMRT witnessed a more than double reduction in pneumonitis compared to the patients who received 3D-conformal radiotherapy.
To Understand More About this Research: Request a Free Sample Report
Moreover, the emergence of numerous cancer types, such as brain cancer, breast cancer, lung cancer, and more, is anticipated to boost market growth during the forecast period. According to a research study, intensity-modulated radiotherapy was more widely employed in treating breast, prostate, and lung cancers in 2018.
However, the higher initial costs associated with the radiation machines and the need for more proficient professionals in handling intensity-modulated radiotherapy are expected to hamper market growth.
Growth Drivers
The rising application of intensity-modulated radiotherapy is driving the market growth
The growing adoption of radiotherapy in cancer treatment is showcasing room for growth in the market scope. According to the available data, there has been an 18% growth in the use of intensity-modulated radiotherapy, from 1,921 patients in 2011 to 34,759 in 2018. This trend is showcasing the positive rate of IMRT adoption in cancer treatment. With its higher potential for the elimination of cancer cells, there will be a significant need for IMRT in the coming years, according to the intensity-modulated radiotherapy market forecast. Accordingly, the market drivers showcase the growing requirement for IMRT and its utilization in the treatment of cancer.
The increasing investments in the development of healthcare infrastructure is boosting the market growth
As more people get infected with cancer, governments are stepping forward to take significant measures to control and promote cancer treatment availability. The enhanced accessibility of healthcare facilities in metropolitan areas is demonstrating a positive outlook for market growth. Based on the research study, around 70% of the patients received IMRT in metropolitan areas, such as Incheon, Gyeonggi Province, and Seoul, in 2018. This is a sign of the demand potential for intensity-modulated radiotherapy in metropolitan areas. Accordingly, market drivers identify the growing importance of healthcare infrastructure across the globe to provide a boost towards the treatment of cancer.
Restraining Factors
The development of alternative therapies is likely to impede market growth
The ongoing market dynamics including research activities and clinical studies exploring other potential treatments for cancer are expected to restrain market growth. For instance, a 2023 clinical study funded by the National Cancer Institute revealed that people with locally advanced rectal cancer, which means the spread of cancer within the rectal rather than other organs, may not be required to have radiation before surgery. These developments are anticipated to restrain the intensity-modulated radiotherapy market in the long run.
Report Segmentation
The market is primarily segmented based on radiation type, application, end user and region.
|
By Radiation Type |
By Application |
By End User |
By Region |
|
|
|
|
To Understand the Scope of this Report: Speak to Analyst
By Radiation Type Analysis
Proton radiation segment is expected to witness the highest growth during the forecast period
Based on market forecast the proton radiation segment is expected to witness the highest CAGR during the projected period, mainly driven by its capabilities to ensure the safety of healthy tissues while eliminating cancer-infected cells. The rising emphasis on long-term side effects of radiation treatment for healthy organs is enabling doctors and other healthcare professionals to adopt intensity-modulated radiotherapy around the world.
The photon radiation segment led the industry market with a substantial market size in 2023, largely attributable to its ability to offer customized radiotherapy, particularly focusing on the target area. The existing familiarity of photon radiation in intensity-modulated radiotherapy and its efficiency in treating cancer cells is likely to propel IMRT market growth in the coming years.
By Application Analysis
Brain cancer segment acquired the largest market share in 2023
Based on market segments of application, the brain cancer segment registered the largest market share in 2023 and is likely to stimulate its market position throughout the forecast period. The ongoing patient interest in non-invasive cancer treatment is contributing to the higher segmental growth over other IMRT applications. Moreover, the rising incidence of brain cancer and the established radiotherapy equipment in the world are expected to drive new demand in the study period.
Based on market analysis, the prostate cancer segment is expected to witness significant growth in the coming years, driven by the growing number of people diagnosed with prostate cancer. According to the cancer statistics published by the American Cancer Society, there was a rise of 3% in the number of prostate cancer cases annually from 2014 to 2019. As this trend continues further, there will be a significant demand for advanced cancer therapies, including radiation therapy, in the projected timeframe.
By End User Analysis
Hospitals segment held the significant market revenue share in 2023
Based on market segments of end user, the hospitals segment held a significant share in 2023 due to the continuous rise in healthcare infrastructure, including x-rays and radiotherapy adoption by hospitals, driven by the growing number of cancer cases. The improved availability of proficient professionals and advanced equipment is forcing patients to get appointments in the hospital, facilitating the potential demand for intensity-modulated radiotherapy.
Based on market analysis, the independent radiotherapy centers segment is anticipated to witness substantial growth in the coming years, driven by factors such as cost-effectiveness being preferred by patients. Further, increasing cases of patient references witnessed from hospitals towards independent radiotherapy centers rather than establishing them in their location will boost the demand for IMRT during the forecast period.
Regional Insights
North America region registered the largest share of the global market in 2023
The North American region registered the largest share in the year 2023. The presence of healthcare providers with rigid infrastructure in the territory influences the region’s growth. The growing investments by the major players are positively influencing market growth. For instance, in June 2022, Netcare Ltd. introduced a new radiation unit at Netcare Milpark Hospital to provide tailored supportive care and treatment to patients.
The Asia Pacific region is projected to grow with a healthy CAGR during the forecast period, owing to the growing concerns about promoting health infrastructure, primarily cancer care, driven by the rising number of cancer patients in the region. The developing countries in the region, primarily India, are focusing more on enhancing the accessibility of cancer care to the public. For instance, the Indian government inaugurated an initial public proton beam therapy facility on the Kharagpur Tata Memorial campus.
Furthermore, according to the IARC (International Association of Cancer Registries), India is witnessing a rise in the number of brain tumor cases, constituting 20% of the total among children. Based on the data, in India, around 28,000 cases of brain tumors are reported. Accordingly, due to the steep rise of such brain tumor cases is expected to drive demand for intensity-modulated radiotherapy during the forecast period.
Key Market Players & Competitive Insights
Strategic partnerships to drive the competition
The intensity-modulated radiotherapy market is fragmented with the presence of several market players and is anticipated to witness competition driven by strategic expansion activities by the major players. For instance, in July 2023, Apollo Hospitals announced its plan to develop two more proton cancer centers in India.
Some of the major players operating in the global market include:
- Accuray Incorporated (US)
- Brainlab AG (Germany)
- Elekta AB (Sweden)
- Hitachi, Ltd. (Japan)
- IBA Dosimetry (Germany)
- Mevion Medical Systems (US)
- Mitsubishi Electric Corporation (Japan)
- Panacea Medical Technologies Pvt. Ltd. (India)
- ProNova Solutions, LLC (US)
- ProTom International (US)
- RaySearch Laboratories AB (Sweden)
- Siemens Healthineers (Germany)
- Sumitomo Heavy Industries, Ltd. (Japan)
- Varian Medical Systems, Inc. (US)
- ViewRay, Inc. (USA)
Recent Developments in the Industry
In June 2023, RaySearch Laboratories AB entered a strategic collaboration with a Japanese medical company, B dot Medical Inc., to develop software solutions for proton therapy. The collaboration is aiming to drive advancements in the development of proton therapy.
Report Coverage
The intensity modulated radiotherapy market report emphasizes key regions across the globe to provide a better understanding of the product to the users. Also, the market dynamics provides market insights into recent developments and trends and analyzes the technologies that are gaining traction around the globe. Furthermore, the market scope covers an in-depth qualitative analysis pertaining to various paradigm shifts associated with the transformation of these solutions.
The market report provides a detailed analysis of the market while focusing on various key aspects such as competitive analysis, radiation type, application, end user, and their futuristic growth opportunities.
Intensity Modulated Radiotherapy Market Report Scope
|
Report Attributes |
Details |
|
Market size value in 2024 |
USD 1.76 billion |
|
Revenue forecast in 2032 |
USD 2.59 billion |
|
CAGR |
5.0% from 2024 – 2032 |
|
Base year |
2023 |
|
Historical data |
2019 – 2022 |
|
Forecast period |
2024 – 2032 |
|
Quantitative units |
Revenue in USD billion and CAGR from 2024 to 2032 |
|
Segments covered |
|
|
Regional scope |
|
|
Competitive Landscape |
|
|
Report Format |
|
|
Customization |
Report customization as per your requirements with respect to countries, region and segmentation. |
FAQ's
The Intensity Modulated Radiotherapy Market report covering key segments are radiation type, application, end user and region.
Intensity Modulated Radiotherapy Market Size Worth $2.59 Billion
Intensity Modulated Radiotherapy Market exhibiting a CAGR of 5.2% during the forecast period.
North America is leading the global market
key driving factors in Intensity Modulated Radiotherapy Market are rising application of intensity-modulated radiotherapy
